Skip to content

Author

Christoph Wanner

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

BACKGROUND AND AIMS Hypertension is a common attributable cause of chronic kidney disease (CKD). Mineralocorticoid receptor overactivation can lead to hypertension and contributes to CKD progression. In FIND-CKD, finerenone reduced kidney function decline in participants with CKD without diabetes. This prespecified FIN...

H. Heerspink, Jelle M. Beernink, R. Agarwal et al. · 0 citations
Review Open access Oct 2026

Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease

Importance There is uncertainty about the effects of intensive blood pressure (BP) lowering on risks of cardiovascular disease and kidney failure in patients with chronic kidney disease (CKD). Objective To assess the standardized effects of intensive BP lowering on cardiovascular and kidney outcomes overall, and then t...

F. Iatridi, Alistair J. Roddick, N. Staplin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.